Intermittent treatment of duodenal ulcer for long term medical management
- PMID: 2901744
Intermittent treatment of duodenal ulcer for long term medical management
Abstract
Most patients with duodenal ulcer relapse but in individuals the events is unpredictable and complications are rare. Two methods of long term treatment have been developed: daily maintenance treatment to prevent relapse; and intermittent treatment, in which individual symptomatic relapses are treated with a short healing course. Pooling the results of three studies on intermittent treatment where cimetidine was used, the number of relapses in one year and the proportion of patients who relapsed were: no relapse, 26%; 1 relapse, 33%; 2 relapses, 24%; greater than or equal to 3 relapses, 17%. Thus, 83% of patients on average have less than or equal to 2 attacks per year, which can be rapidly controlled with a short course of treatment. In comparative trials, relapse on maintenance treatment is much less than on intermittent treatment, as would be expected, but the clinical advantage of the former is relatively small and obtained at a much higher cost in drugs. However, in practice, the two treatments are complementary, not competitive, and patients in whom maintenance treatment (or surgery) is necessary would not be considered for intermittent treatment. Most work on intermittent treatment has been done with histamine H2 receptor antagonists. Theoretically, better results might be achieved by increasing the healing rate with omeprazole or more effectively, by reducing the spontaneous relapse rate by healing with colloidal bismuth. Intermittent treatment is contraindicated in the one-third who are either 'high-risk' patients or those who have aggressive ulcer disease. It is suitable for the two-thirds who meet all the following criteria: age <60 years; no associated serious illness; no previous haemorrhage or perforation; not on regular treatment with non-steroidal anti-inflammatory drugs; symptoms develop gradually (se that treatment can be started before pain worsens); less than or equal 2 relapses per year; ulcer is non-refractory. It is essential to establish an accurate diagnosis before starting therapy. Treatment is given for a month and repeated when typical symptoms recur. Repeat endoscopy is not needed except in special circumstances. For the majority of patients, intermittent treatment is an effective, simple and economical way of providing long term treatment.
Similar articles
-
Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.Yale J Biol Med. 1996 May-Jun;69(3):211-24. Yale J Biol Med. 1996. PMID: 9165690 Free PMC article. Review.
-
Long-term treatment for gastric and duodenal ulcer.Ital J Gastroenterol. 1990;22 Suppl 2:24-8. Ital J Gastroenterol. 1990. PMID: 1983413 Review.
-
A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S89-92. Ital J Gastroenterol Hepatol. 1999. PMID: 10379475 Review.
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
-
Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S54-62. Ital J Gastroenterol Hepatol. 1999. PMID: 10379471
Cited by
-
Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.Pharmacoeconomics. 1993 Jun;3(6):482-510. doi: 10.2165/00019053-199303060-00008. Pharmacoeconomics. 1993. PMID: 10146883 Review.
-
Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.Drugs. 1991 Jul;42(1):138-70. doi: 10.2165/00003495-199142010-00008. Drugs. 1991. PMID: 1718683 Review.
-
Optimizing acid suppression for treatment of acid-related diseases.Dig Dis Sci. 1995 Feb;40(2 Suppl):24S-49S. doi: 10.1007/BF02214870. Dig Dis Sci. 1995. PMID: 7859582 Review.
-
Long term treatment of duodenal ulcer. A review of management options.Drugs. 1991 Jan;41(1):38-51. doi: 10.2165/00003495-199141010-00004. Drugs. 1991. PMID: 1706986 Review.
-
Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.Gut. 1995 Aug;37(2):195-8. doi: 10.1136/gut.37.2.195. Gut. 1995. PMID: 7557567 Free PMC article.